Form D · Biotechnology
Navigator Medicines, Inc.
San Mateo, CA · CIK 0002035715
Offering snapshot reported Sep 25, 2026 · SEC filing
- Reported sold
- $10M Offering amount: $40M
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 18, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 25, 2026 | Initial | $10,000,000 | No comparison | 3 | SEC filing |
| Sep 5, 2024 | Initial | $49,999,998 | No comparison | 4 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-598829
Source: Form D, filed Sep 25, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| William Daley Bonificio | Executive, Promoter |
| Tausif Butt | Director, Executive, Promoter |
| Naveen Manu Daryani | Executive |
| Khurem Farooq | Director |
| Scott Forrest | Executive |
| Kristie Grebe | Executive |
| Wouter Joustra | Director |
| Andrew Levin | Director |
| Stephen Basil Thomas | Director, Executive, Promoter |
| Mathias Vinther | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
1825 S Grant St. Suite 200
San Mateo, CA, 94402
Phone: 650-240-8794
San Mateo, CA, 94402
Phone: 650-240-8794